BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25056722)

  • 21. Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis.
    Katoh M; Egashira K; Mitsui T; Chishima S; Takeshita A; Narita H
    J Mol Cell Cardiol; 2000 Jan; 32(1):73-83. PubMed ID: 10652192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated tissue expression of thrombomodulatory factors correlates with acute symptomatic carotid plaque phenotype.
    Sayed S; Cockerill GW; Torsney E; Poston R; Thompson MM; Loftus IM
    Eur J Vasc Endovasc Surg; 2009 Jul; 38(1):20-5. PubMed ID: 19356953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum amyloid A receptor blockade and incorporation into high-density lipoprotein modulates its pro-inflammatory and pro-thrombotic activities on vascular endothelial cells.
    Chami B; Barrie N; Cai X; Wang X; Paul M; Morton-Chandra R; Sharland A; Dennis JM; Freedman SB; Witting PK
    Int J Mol Sci; 2015 May; 16(5):11101-24. PubMed ID: 25988387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin II increases plasminogen activator inhibitor-1 and tissue factor mRNA expression without changing that of tissue type plasminogen activator or tissue factor pathway inhibitor in cultured rat aortic endothelial cells.
    Nishimura H; Tsuji H; Masuda H; Nakagawa K; Nakahara Y; Kitamura H; Kasahara T; Sugano T; Yoshizumi M; Sawada S; Nakagawa M
    Thromb Haemost; 1997 Jun; 77(6):1189-95. PubMed ID: 9241756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amiodarone inhibits arterial thrombus formation and tissue factor translation.
    Breitenstein A; Stämpfli SF; Camici GG; Akhmedov A; Ha HR; Follath F; Bogdanova A; Lüscher TF; Tanner FC
    Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2231-8. PubMed ID: 18974383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonin induces the expression of tissue factor and plasminogen activator inhibitor-1 in cultured rat aortic endothelial cells.
    Kawano H; Tsuji H; Nishimura H; Kimura S; Yano S; Ukimura N; Kunieda Y; Yoshizumi M; Sugano T; Nakagawa K; Masuda H; Sawada S; Nakagawa M
    Blood; 2001 Mar; 97(6):1697-702. PubMed ID: 11238110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smoking is associated with altered endothelial-derived fibrinolytic and antithrombotic factors: an in vitro demonstration.
    Barua RS; Ambrose JA; Saha DC; Eales-Reynolds LJ
    Circulation; 2002 Aug; 106(8):905-8. PubMed ID: 12186791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential.
    Lockwood CJ; Krikun G; Aigner S; Schatz F
    J Clin Endocrinol Metab; 1996 Jan; 81(1):107-12. PubMed ID: 8550736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemostatic effect of acylated ghrelin in control and sleeve gastrectomy-induced rats: mechanisms of action.
    Morsy MD
    Arch Physiol Biochem; 2020 Feb; 126(1):31-40. PubMed ID: 30320517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
    Falciani M; Gori AM; Fedi S; Chiarugi L; Simonetti I; Dabizzi RP; Prisco D; Pepe G; Abbate R; Gensini GF; Neri Serneri GG
    Thromb Haemost; 1998 Mar; 79(3):495-9. PubMed ID: 9531029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy.
    Sorrentino SA; Besler C; Rohrer L; Meyer M; Heinrich K; Bahlmann FH; Mueller M; Horváth T; Doerries C; Heinemann M; Flemmer S; Markowski A; Manes C; Bahr MJ; Haller H; von Eckardstein A; Drexler H; Landmesser U
    Circulation; 2010 Jan; 121(1):110-22. PubMed ID: 20026785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemostasis imbalance in experimental hypertension.
    Corseaux D; Ollivier V; Fontaine V; Huisse MG; Philippe M; Louedec L; Vranckx R; Ravanat C; Lanza F; Angles-Cano E; Guillin MC; Michel JB
    Mol Med; 2002 Apr; 8(4):169-78. PubMed ID: 12149566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imbalance of plasminogen activator inhibitor-I/ tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction.
    Saigo M; Abe S; Ogawa M; Yamashita T; Biro S; Minagoe S; Maruyama I; Tei C
    Thromb Haemost; 2001 Nov; 86(5):1197-203. PubMed ID: 11816707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-density lipoproteins as modulators of endothelial cell functions: alterations in patients with coronary artery disease.
    Kratzer A; Giral H; Landmesser U
    Cardiovasc Res; 2014 Aug; 103(3):350-61. PubMed ID: 24935432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute coronary syndrome remodels the antiplatelet aggregation properties of HDL particle subclasses.
    Garcia C; Montée N; Faccini J; Series J; Meilhac O; Cantero AV; Le Faouder P; Elbaz M; Payrastre B; Vindis C
    J Thromb Haemost; 2018 May; 16(5):933-945. PubMed ID: 29543379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prothrombotic gene expression profile in vascular smooth muscle cells of human saphenous vein, but not internal mammary artery.
    Payeli SK; Latini R; Gebhard C; Patrignani A; Wagner U; Lüscher TF; Tanner FC
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):705-10. PubMed ID: 18258816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of simvastatin on cigarette smoke extract induced tissue-type plasminogen activator and plasminogen activator inhibitor-1 expression in human umbilical vein endothelial cells.
    Hu XY; Ma YH; Wang C; Yang YH
    Chin Med J (Engl); 2009 Oct; 122(19):2380-5. PubMed ID: 20079143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential roles of plasminogen activator system in coronary vascular remodeling induced by long-term nitric oxide synthase inhibition.
    Kaikita K; Schoenhard JA; Painter CA; Ripley RT; Brown NJ; Fogo AB; Vaughan DE
    J Mol Cell Cardiol; 2002 Jun; 34(6):617-27. PubMed ID: 12054849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant full-length tissue factor pathway inhibitor (TFPI) prevents thrombus formation and rethrombosis after lysis in a rabbit model of jugular vein thrombosis.
    Kaiser B; Fareed J
    Thromb Haemost; 1996 Oct; 76(4):615-20. PubMed ID: 8903005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pro-atherothrombotic effects of leptin in human coronary endothelial cells.
    Cirillo P; Angri V; De Rosa S; Calì G; Petrillo G; Maresca F; D'Ascoli GL; Maietta P; Brevetti L; Chiariello M
    Thromb Haemost; 2010 May; 103(5):1065-75. PubMed ID: 20174754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.